Moreover, in people with rheumatoid arthritis, IL‐6 inhibitor therapy results in rapid QTc shortening in 3–6 months (Capecchi et al., 2019; Kobayashi et al., 2018; Lazzerini et al., 2015). This evidence concerns the gene IL6 and rheumatoid arthritis.